James F. Rea

Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Multiple NFL players, including Cooper Kupp, were inactive or dealing with injuries in Week 9, leading to roster changes and depth challenges for their teams.
  • Fox Corp reports strong Q1 results, announces $1.5B buyback, but free cash flow turns negative.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Multiple NFL players, including Cooper Kupp, were inactive or dealing with injuries in Week 9, leading to roster changes and depth challenges for their teams.
  • Fox Corp reports strong Q1 results, announces $1.5B buyback, but free cash flow turns negative.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from James F. Rea